Cardiovascular Medicine

4 pages, 145 KB

Open AccessCommunication

Jahresbericht 2003 der Arbeitsgruppe Interventionelle Kardiologie und Akutes Koronarsyndrom

by Franz Eberli, Hans Rickli, Giovanni Pedrazzini, André Vuilliomenet and Pascal Chatelain

Cardiovasc. Med. 2005, 8(2), 69; https://doi.org/10.4414/cvm.2005.01077 - 25 Feb 2005

Viewed by 45

Abstract

General: The Working Group had 111 members [...] Full article

1 pages, 157 KB

Open AccessInteresting Images

Von Hippel-Lindau-Syndrom

by C. Henzen

Cardiovasc. Med. 2005, 8(2), 66; https://doi.org/10.4414/cvm.2005.01076 - 25 Feb 2005

Viewed by 43

Abstract

Fallbeschreibung: 29jährige Patientin mit St. n. beidseitiger adrenaler Phäochromozytom-Entfernung 1985 sowie Amaurosis nach Enukleation links bei Angiomatosis retinae [...] Full article

► Show Figures

Figure 1

2 pages, 154 KB

Open AccessInteresting Images

Braucht Ein Spitzensportler Einen Schrittmacher?

by Beat Schaer and Stefan Osswald

Cardiovasc. Med. 2005, 8(2), 64; https://doi.org/10.4414/cvm.2005.01078 - 25 Feb 2005

Viewed by 47

Abstract

Bei dem 18jährigen Mann wurde anlässlich einer Varikozelen-Operation eine Pulsunregelmässigkeit festgestellt und eine kardiale Abklärung empfohlen [...] Full article

► Show Figures

Figure 1

2 pages, 199 KB

Open AccessCase Report

Caseous Calcification of the Mitral Annulus

by Andreas H. Fischer, Lukas Spieker, David Pfeiffer, René Prêtre, Christine Attenhofer Jost and Rolf Jenni

Cardiovasc. Med. 2005, 8(2), 62; https://doi.org/10.4414/cvm.2005.01079 - 25 Feb 2005

Viewed by 38

Abstract

Case description: A 71-year-old woman with long-standing hypertension was referred for cardiological evaluation because of dyspnea on exertion, orthopnea, and orthostatic dizziness [...] Full article

► Show Figures

Figure 1

8 pages, 279 KB

Open AccessEditorial

Catheter Ablation for Atrial Fibrillation: Pathophysiology, Techniques, Results and Current Indications

by Christoph Scharf, J. Schläpfer, C. Sticherling, S. Osswald, J. Fuhrer and D. C. Shah

Cardiovasc. Med. 2005, 8(2), 53; https://doi.org/10.4414/cvm.2005.01074 - 25 Feb 2005

Viewed by 39

Abstract

Introduction Atrial fibrillation (AF) is the most common sustained arrhythmia in adults affecting about 6% of the population over the age of 60 [...] Full article

► Show Figures

Figure 1

9 pages, 197 KB

Open AccessArticle

Die Wirtschaftlichkeit Beschichteter Stents in der Interventionellen Kardiologie—Eine Gesamtschweizerische Analyse

by Thomas D. Szucs, Matthias Schwenkglenks, Thomas F. Lüscher and Franz Eberli

Cardiovasc. Med. 2005, 8(2), 41; https://doi.org/10.4414/cvm.2005.01080 - 25 Feb 2005

Viewed by 40

Abstract

Objectives of study: Calculating the direct and indirect costs of using coated coronary stents (DES = drug eluting stents) compared with uncoated stents (BMS = bare metal stents) in interventional cardiology, and computation of the anticipated overall costs in Switzerland. Method: [...] Read more.

Objectives of study: Calculating the direct and indirect costs of using coated coronary stents (DES = drug eluting stents) compared with uncoated stents (BMS = bare metal stents) in interventional cardiology, and computation of the anticipated overall costs in Switzerland. Method: Model-based cost computation on the basis of clinical meta-analyses, register analyses, epidemiological and Swiss cost data. The perspective was that of the statutory sickfunds. Result: Implantation of DES instead of the BMS used hitherto results, in view of the high procurement costs, in an additional average expenditure per patient of CHF 1673. The additional costs occasioned by revascularisation measures for restenosis are, however, reduced by an average of CHF 2419 per patient by DES implantation instead of BMS implantation. Thus, overall and in all the patient groups studied, DES implantation is a cost-saving factor in Switzerland since the savings from averted revascularisation measures exceed the higher procurement costs of DES. The average saving is CHF 745 per patient. Through the additional replacement of bypass surgery, DES implantation allows further cost savings. The latter are realised more rapidly since implantation of DES in place of the BMS can be performed on a routine basis. Conclusion: Implantation of DES instead of BMS is a net cost-saving intervention in the Swiss health care system. Full article

2 pages, 136 KB

Open AccessEditorial

Gibt es Kosteneffiziente Fortschritte in der Medizin?

by Thomas F. Lüscher

Cardiovasc. Med. 2005, 8(2), 39; https://doi.org/10.4414/cvm.2005.01075 - 25 Feb 2005

Cited by 2 | Viewed by 40

Abstract

Die Medizin hat vor allem in den letzten 50 Jahren enorme Fortschritte aufzuweisen, welche die Behandlung und auch Prävention von verschiedenen Erkrankungen erheblich verbessert hat [...] Full article

Journal Menu

Journal Browser

Cardiovasc. Med., Volume 8, Issue 2 (02 2005) – 7 articles

Further Information

Guidelines

MDPI Initiatives

Follow MDPI